Bulletin
Investor Alert

Harrow Health Inc.

NAS: HROW

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 7:05 p.m.

/zigman2/quotes/206805265/composite

$

5.90

Change

0.00 0.00%

Volume

Volume 69,836

Quotes are delayed by 20 min

/zigman2/quotes/206805265/composite

Previous close

$ 5.77

$ 5.90

Change

+0.13 +2.25%

Day low

Day high

$5.77

$6.00

Open

52 week low

52 week high

$5.40

$12.99

Open

John P. Saharek

John P. Saharek is President-ImprimisRx at Harrow Health, Inc.

In the past he was Vice President-Business Development for SurModics, Inc. and Head-US Marketing & Strategy at Thrombogenics, Inc.

He received an MBA from the University of Hartford and an undergraduate degree from Central Connecticut State University.

Transactions

Date Shares Transaction Value
02/19/2022 25,923   Derivative/Non-derivative trans. at $7.87 per share. 204,015
02/19/2022 50,000   Derivative/Non-derivative trans. at $0 per share. 0
02/01/2018 30,000   Derivative/Non-derivative trans. at $1.83 per share. 54,900

Officers and Executives

Mr. Mark L. Baum
Chairman & Chief Executive Officer
Mr. Andrew R. Boll
Chief Financial Officer & Secretary
Dr. Larry M. Dillaha
Chief Medical Officer
Mr. Andrew Livingston
Chief Innovation Officer
Mr. John P. Saharek
President-ImprimisRx
Dr. Richard L. Lindstrom
Director
Ms. Teresa F. Sparks
Independent Director
Dr. R. Lawrence van Horn
Independent Director
Mr. Perry J. Sternberg
Independent Director
Dr. Marty Makary
Independent Director
Link to MarketWatch's Slice.